@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wdtn: <http://www.wikidata.org/prop/direct-normalized/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q17148583 rdfs:label "PARAMOUNT-Studie"@de,
        "PARAMOUNT trial"@en,
        "preskušanje PARAMOUNT"@sl,
        "PARAMOUNT trial"@tr,
        "випробування PARAMOUNT"@uk ;
    schema1:dateModified "2026-02-08T22:57:56+00:00"^^xsd:dateTime ;
    schema1:description "ensayu clínicu"@ast,
        "klinische Studie"@de,
        "clinical trial studying non-small-cell lung carcinoma"@en,
        "klinisch onderzoek"@nl,
        "klinična raziskava zdravljenja nedrobnoceličnega karcinoma pljuč"@sl,
        "küçük hücreli olmayan akciğer karsinomunu inceleyen klinik çalışma"@tr ;
    schema1:version 2461852103 ;
    wikibase:identifiers 3 ;
    wikibase:sitelinks 2 ;
    wikibase:statements 17 ;
    skos:altLabel "A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment with Pemetrexed + Cisplatin"@en,
        "Dvojno slepa, s placebom nadzorovana študija faze 3 vzdrževalnega zdravljenja s pemetreksedom in najboljšim podpornim zdravljenjem v primerjavi z najboljšim podpornim zdravljenjem takoj po uvodnem zdravljenju s pemetreksedom + cisplatinom"@sl,
        "Raziskava indukcijskega in vzdrževalnega zdravljenja napredovalega neploščatoceličnega nedrobnoceličnega raka pljuč"@sl,
        "Pemetrexed + Cisplatin ile İndüksiyon Tedavisinin Hemen Ardından Pemetrexed ile En İyi Destekleyici Bakıma karşı En İyi Destekleyici Bakıma karşı Aşama 3, Çift Kör, Plasebo Kontrollü Bakım Çalışması"@tr ;
    p:P1132 wds:Q17148583-47835cff-4de7-f125-632a-3ff8ee3d67ff ;
    p:P1476 wds:Q17148583-4e9b5886-4a8e-3ebc-1d80-5f7fd39672be ;
    p:P18 wds:Q17148583-6b2fd5ca-4ea0-2847-61da-e9004549bbcb ;
    p:P1813 wds:Q17148583-a2ecf3e6-48a6-631c-6e77-a02c0549adf0 ;
    p:P2175 wds:Q17148583-37F210BF-AE2B-43F9-A869-A0B7253DDFDD ;
    p:P2899 wds:Q17148583-D1695A31-F0B0-4A66-A5BD-65D03E622140 ;
    p:P3098 wds:Q17148583-19313781-4bae-3bca-6d29-0ffe19de59f1 ;
    p:P31 wds:Q17148583-d8e04016-4aa3-849f-e924-858b658669e5 ;
    p:P373 wds:Q17148583-335EABF9-0914-4EF5-A646-E37DB035A69E ;
    p:P4844 wds:Q17148583-B3205276-954A-4A3A-9F8A-8BBE0B72CCCE ;
    p:P580 wds:Q17148583-a09ea56a-417e-29ee-293c-dc94e13e65d3 ;
    p:P582 wds:Q17148583-2455b9e5-44d0-ef82-f50e-a34f356f8ad7 ;
    p:P6099 wds:Q17148583-057EBFB3-69E9-4D46-83E8-1CF77C22FD07 ;
    p:P6366 wds:Q17148583-532AE2B6-A04F-425C-A216-A20E9843B433 ;
    p:P646 wds:Q17148583-E93E9204-27E6-412F-B70A-5E174C56D6E7 ;
    p:P8363 wds:Q17148583-2CD681F0-EA89-4AE1-9A6B-6C7A335CB7AF ;
    p:P859 wds:Q17148583-8b5491d8-4d27-c923-e782-18dd44da21cc ;
    wdtn:P6366 <https://makg.org/entity/2778879742> ;
    wdt:P1132 939.0 ;
    wdt:P1476 "A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer"@en ;
    wdt:P18 <http://commons.wikimedia.org/wiki/Special:FilePath/PARAMOUNT%20Eli%20Lilly%20Informed%20Consent%20Document.djvu> ;
    wdt:P1813 "PARAMOUNT trial"@en ;
    wdt:P2175 wd:Q47912 ;
    wdt:P2899 18.0 ;
    wdt:P3098 "NCT00789373" ;
    wdt:P31 wd:Q30612 ;
    wdt:P373 "PARAMOUNT trial" ;
    wdt:P4844 wd:Q415220 ;
    wdt:P580 "2008-11-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P582 "2013-09-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P6099 wd:Q42824827 ;
    wdt:P6366 "2778879742" ;
    wdt:P646 "/m/0x215cf" ;
    wdt:P8363 wd:Q9164018 ;
    wdt:P859 wd:Q632240 .